期刊文献+

溴隐亭治疗男性垂体泌乳素大腺瘤

BROMOCRIPTINE TREATMENT OF MALE PITUITARY PROLACTIN-PRODUCING MACROADENOMA
原文传递
导出
摘要 本文报告5例男性垂体PRL大腺瘤的临床表现及溴隐亭的疗效。患者病程长、以性功能障碍为主诉,有垂体瘤压迫症状,血PRL水平升高,血T水平降低,严重者无精子。对溴隐亭试验敏感者疗效好,血PRL水平下降至正常,血T水平上升,性功能改善,生精作用恢复,垂体瘤也有明显缩小。 The therapeutic effect of bromocriptine on 5 male patients with pituitary PRL-producing macroadenoma was observed and discussed. After treated with a dosage of 7.5 mg/d, 4 patients showed a decrease of serum PRL level, an increase of serum T concentration, improvement of sexual function, restoration of spermatogenesis, and shrinkage of tumor size. One patient had no improvement both clinically and in serum hormone levels even after the dosage of bromocriptine was increased to 30 mg/d. Bromocriptine sensitive test is very useful in predicting the therapeutic effect of bromocriptine in pituitary PRL-producing macroadenoma.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 1990年第2期93-95,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 垂体泌乳素 腺瘤 溴隐亭 男性 Pituitary prolactin-producing macroadenoma Bromocriptine-therapy Bromocriptine sensitive test Sexual dysfunction
  • 相关文献

参考文献1

  • 1金自孟,中华内科杂志,1986年,25卷,475页

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部